These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 21455197

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan.
    Hirokawa M, Higuchi M, Suzuki A, Hayashi T, Kuma S, Miyauchi A.
    Endocr J; 2020 Oct 28; 67(10):1071-1075. PubMed ID: 32595200
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma.
    Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, Rumilla K, Lloyd RV.
    Endocr Pathol; 2006 Oct 28; 17(3):213-23. PubMed ID: 17308358
    [Abstract] [Full Text] [Related]

  • 24. Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential.
    Papotti M, Rodriguez J, De Pompa R, Bartolazzi A, Rosai J.
    Mod Pathol; 2005 Apr 28; 18(4):541-6. PubMed ID: 15529186
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
    Kakudo K, Bai Y, Liu Z, Li Y, Ito Y, Ozaki T.
    Endocr J; 2012 Apr 28; 59(1):1-12. PubMed ID: 21908930
    [Abstract] [Full Text] [Related]

  • 28. Immunohistochemical analysis of thyroid follicular neoplasms and BRAF mutation correlation.
    Atik E, Guray M, Gunesacar R, Ozgur T, Canda T.
    Indian J Cancer; 2014 Apr 28; 51(1):63-8. PubMed ID: 24947099
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
    Aiad HA, Bashandy MA, Abdou AG, Zahran AA.
    Pathol Oncol Res; 2013 Apr 28; 19(2):167-75. PubMed ID: 23055017
    [Abstract] [Full Text] [Related]

  • 34. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
    Guyétant S, Michalak S, Valo I, Saint-André JP.
    Ann Pathol; 2003 Feb 28; 23(1):11-20. PubMed ID: 12743496
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A, Etit D, Bayol U, Altinel D, Tan S.
    Ann Diagn Pathol; 2011 Apr 28; 15(2):108-16. PubMed ID: 21315633
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec 28; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.